CaerusX Yatiri Bio SPV, a Series of Vauban Platform LP — Form D
CaerusX Yatiri Bio SPV, a Series of Vauban Platform LP of NEWARK, DE, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2024-08-28. The offering totals $130K, of which $130K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-08-28
- Form: D
- Accession: 0002035425-24-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $130K
- Amount sold: $130K
- Minimum investment: $1K
- Investors: 5
- Date of first sale: 2024-08-26
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-522615
Issuer
- Name: CaerusX Yatiri Bio SPV, a Series of Vauban Platform LP
- CIK: 0002035425
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 131 CONTINENTAL DRIVE, NEWARK, DE, 19713
- Phone: 4342380920
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Charly Kevers | Executive Officer | New York, NY |
| Henry Shozen Ward | Executive Officer | New York, NY |
| - Vauban Advisers LLC | Promoter | New York, NY |
| - Vauban Capital GP LLC | Promoter | New York, NY |
More